These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8911233)

  • 1. Alterations of membrane phospholipid metabolism in patients with schizophrenia assessed by phosphorus magnetic resonance spectroscopy.
    George TP; Spence MW
    Arch Gen Psychiatry; 1996 Nov; 53(11):1065-6. PubMed ID: 8911233
    [No Abstract]   [Full Text] [Related]  

  • 2. 31P magnetic resonance spectroscopy studies in schizophrenia.
    Williamson PC; Brauer M; Leonard S; Thompson T; Drost D
    Prostaglandins Leukot Essent Fatty Acids; 1996 Aug; 55(1-2):115-8. PubMed ID: 8888133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An in vivo study of the prefrontal cortex of schizophrenic patients at different stages of illness via phosphorus magnetic resonance spectroscopy.
    Stanley JA; Williamson PC; Drost DJ; Carr TJ; Rylett RJ; Malla A; Thompson RT
    Arch Gen Psychiatry; 1995 May; 52(5):399-406. PubMed ID: 7726721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain cell membrane motion-restricted phospholipids: a cerebral 31-phosphorus magnetic resonance spectroscopy study of patients with schizophrenia.
    Puri BK; Counsell SJ; Hamilton G
    Prostaglandins Leukot Essent Fatty Acids; 2008 Dec; 79(6):233-5. PubMed ID: 18842398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prefrontal membrane phospholipid metabolism of child and adolescent offspring at risk for schizophrenia or schizoaffective disorder: an in vivo 31P MRS study.
    Keshavan MS; Stanley JA; Montrose DM; Minshew NJ; Pettegrew JW
    Mol Psychiatry; 2003 Mar; 8(3):316-23, 251. PubMed ID: 12660804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered phospholipid metabolism in schizophrenia: a phosphorus 31 nuclear magnetic resonance spectroscopy study.
    Weber-Fahr W; Englisch S; Esser A; Tunc-Skarka N; Meyer-Lindenberg A; Ende G; Zink M
    Psychiatry Res; 2013 Dec; 214(3):365-73. PubMed ID: 24045051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorus magnetic resonance spectroscopy in schizophrenia: correlation between membrane phospholipid metabolism in the temporal lobe and positive symptoms.
    Fukuzako H; Fukuzako T; Takeuchi K; Ohbo Y; Ueyama K; Takigawa M; Fujimoto T
    Prog Neuropsychopharmacol Biol Psychiatry; 1996 May; 20(4):629-40. PubMed ID: 8843487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Risk for schizophrenia and diagnostic image of cerebral membrane metabolism].
    Klemm S; Gerhard UJ; Blanz B
    Z Kinder Jugendpsychiatr Psychother; 2001 Feb; 29(1):50-8. PubMed ID: 11234552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antipsychotic drug effects on left prefrontal phospholipid metabolism: a follow-up 31P-2D-CSI study of haloperidol and risperidone in acutely ill chronic schizophrenia patients.
    Smesny S; Langbein K; Rzanny R; Gussew A; Burmeister HP; Reichenbach JR; Sauer H
    Schizophr Res; 2012 Jul; 138(2-3):164-70. PubMed ID: 22516552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorus magnetic resonance spectroscopy: its utility in examining the membrane hypothesis of schizophrenia.
    Reddy R; Keshavan MS
    Prostaglandins Leukot Essent Fatty Acids; 2003 Dec; 69(6):401-5. PubMed ID: 14623493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutamatergic dysfunction linked to energy and membrane lipid metabolism in frontal and anterior cingulate cortices of never treated first-episode schizophrenia patients.
    Smesny S; Gussew A; Biesel NJ; Schack S; Walther M; Rzanny R; Milleit B; Gaser C; Sobanski T; Schultz CC; Amminger P; Hipler UC; Sauer H; Reichenbach JR
    Schizophr Res; 2015 Oct; 168(1-2):322-9. PubMed ID: 26255566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regionally Distinct Alterations in Membrane Phospholipid Metabolism in Schizophrenia: A Meta-analysis of Phosphorus Magnetic Resonance Spectroscopy Studies.
    Haszto CS; Stanley JA; Iyengar S; Prasad KM
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2020 Mar; 5(3):264-280. PubMed ID: 31748123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A human in vivo study of the extent to which 31-phosphorus neurospectroscopy phosphomonoesters index cerebral cell membrane phospholipid anabolism.
    Puri BK; Treasaden IH
    Prostaglandins Leukot Essent Fatty Acids; 2009; 81(5-6):307-8. PubMed ID: 19906517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indexation of cerebral cell membrane phospholipid catabolism by the non-invasively determined cerebral 31-phosphorus neurospectroscopic phosphodiester peak.
    Puri BK
    Med Hypotheses; 2012 Feb; 78(2):312-4. PubMed ID: 22136945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 31P magnetic resonance spectroscopy in the dorsolateral prefrontal cortex of schizophrenics with a volume selective technique--preliminary findings.
    Volz HP; Rzanny R; May S; Hegewald H; Preussler B; Hajek M; Kaiser WA; Sauer H
    Biol Psychiatry; 1997 Mar; 41(6):644-8. PubMed ID: 9066987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane phospholipid metabolism and schizophrenia: an in vivo 31P-MR spectroscopy study.
    Stanley JA; Williamson PC; Drost DJ; Carr TJ; Rylett RJ; Morrison-Stewart S; Thompson RT
    Schizophr Res; 1994 Oct; 13(3):209-15. PubMed ID: 7841133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive membrane phospholipid changes in first episode schizophrenia with high field magnetic resonance spectroscopy.
    Miller J; Drost DJ; Jensen E; Manchanda R; Northcott S; Neufeld RW; Menon R; Rajakumar N; Pavlosky W; Densmore M; Schaefer B; Williamson P
    Psychiatry Res; 2012 Jan; 201(1):25-33. PubMed ID: 22284150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 31P nuclear magnetic resonance spectroscopy: neurodevelopment and schizophrenia.
    Pettegrew JW; Keshavan MS; Minshew NJ
    Schizophr Bull; 1993; 19(1):35-53. PubMed ID: 8451612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance imaging volumetric and phosphorus 31 magnetic resonance spectroscopy measurements in schizophrenia.
    Hinsberger AD; Williamson PC; Carr TJ; Stanley JA; Drost DJ; Densmore M; MacFabe GC; Montemurro DG
    J Psychiatry Neurosci; 1997 Mar; 22(2):111-7. PubMed ID: 9074305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton and 31-phosphorus neurospectroscopy in the study of membrane phospholipids and fatty acid intervention in schizophrenia, depression, chronic fatigue syndrome (myalgic encephalomyelitis) and dyslexia.
    Puri BK
    Int Rev Psychiatry; 2006 Apr; 18(2):145-7. PubMed ID: 16777668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.